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Chronic nicotine use is a major public health crisis. Accord-
ing to the World Health Organization, there are nearly 1.2 bil-
lion current smokers worldwide, and more than 4.9 million 
of them die each year of tobacco-related diseases (Esson & 
Leeder, 2004). Although the smoking rates have remained sta-
ble in developed countries, middle and low-income countries 
have seen a steady increase in smoking rates. In these coun-
tries where people can least afford the economic and health 
costs of tobacco use, families in poverty spend up to 15% of 
their disposable income on tobacco products rather than on 
food, education, or health care. The United Nations as part of 
the Millennium Development Goals established in 2000, made 
a call to reduce poverty and promote health and human devel-
opment worldwide (General Assembly, 2000). Cessation of to-
bacco use is inextricably linked to these goals because of the 
dramatic costs of tobacco consumption and control.
One of the objectives of the United States government is to 
reduce smoking rates to less than 12% of adults by 2010 (U.S. 
Department of Health & Human Services, 2000). In 1997 there 
was a smoking prevalence of 24.7%. By 2004, this percentage 
had dropped to 20.9%. However, in 2006 approximately 20.8% 
of adults were current smokers suggesting that the decline in 
smoking in the United States may be stalling in recent years 
(CDC, 2007). Perhaps contributing to this stall is the co-occur-
rence of a decrease in state-funded cessation programs and an 
increase in tobacco company expenditures targeted at main-
taining the customer base (CDC, 2007). Regardless, if the peo-
ple who do receive therapy have a greater likelihood of ces-
sation success, the population of tobacco users will decline. 
Among active smokers in the United States in 2000, approx-
imately 70% wanted to quit using tobacco completely (CDC, 
2002). Of these people, 41% stopped smoking for at least 1 full 
day during the preceding 12 months. Only 4.7% of smokers 
had maintained abstinence for 3 to 12 months. At this rate, the 
2010 goal may be difficult to reach.
One way to reduce the prevalence of smoking is to im-
prove the therapeutic techniques currently in practice. Im-
provements will come from diverse areas of research. These 
areas could inform therapies through studies concerning cul-
tural factors, developmental effects, or genetic bases of vul-
nerability toward addiction. Learning theory informs an-
other area of improvement. Indeed, a greater understanding 
of tobacco use based on Pavlovian conditioning has already 
enhanced behavioral therapy techniques. From this perspec-
tive, the unconditioned stimulus (US) effects, including the 
rewarding properties, of nicotine come to be associated with 
various nondrug stimuli that are repeatedly present dur-
ing drug ingestion (Pavlov, 1927). These conditional stimuli 
(CSs) include environmental contexts as well as more prox-
imal cues such as ashtrays and cigarettes. When tobacco us-
ers are later exposed to these CSs, the stimuli evoke drug-re-
lated physiological, behavioral, and subjective conditioned 
responses (CRs) that lead to craving and drug seeking (Bev-
ins & Palmatier, 2004; Conklin, 2006; Conklin & Tiffany, 2001; 
Drummond, Tiffany, Glautier, & Remington, 1995; Payne, 
Schare, Levis, & Colletti, 1991; Poulos, Hinson, & Siegel, 1981; 
Shiffman et al., 2002; for similar discussion with opioids and 
cocaine, see Childress, Hole, Ehrman, Robbins, McLellan, & 
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Reflects a Pavlovian Conditioned Association
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Abstract
Recent research examining Pavlovian appetitive conditioning has extended the associative properties of nicotine from the unconditioned 
stimulus or reward to include the role of a conditional stimulus (CS), capable of acquiring the ability to evoke a conditioned response. 
To date, published research has used presession extravascular injections to examine nicotine as a contextual CS in that appetitive Pavlov-
ian drug discrimination task. Two studies in the current research examined whether a nicotine CS can function discretely, multiple times 
within a session using passive iv infusions. In Experiment 1, rats readily acquired a discrimination in conditioned responding between 
nicotine and saline infusions when nicotine was selectively paired with sucrose presentations. In Experiment 2, rats were either trained 
with nicotine paired with sucrose or explicitly unpaired with sucrose. The results showed that rats trained with explicitly unpaired nic-
otine and sucrose did not increase dipper entries after the infusions. Nicotine was required to be reliably paired with sucrose for control 
of conditioned responding to develop. Implications of these findings are discussed in relation to tobacco addiction, learning theory, and 
pharmacology.
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O’Brien, 1993). According to conditioning theory, repeated 
exposure to the CS without the nicotine US should decrease 
these drug-related CRs thus decreasing the likelihood of re-
lapse (see Marlatt, 1990; Pavlov, 1927). Indeed, behavioral to-
bacco cessation therapies utilize cue exposure to help reduce 
the occurrence of craving in the presence of tobacco-related 
stimuli (see Conklin, 2006; Conklin & Tiffany, 2002).
Conceptualizing nicotine as a potent US that enters into 
conditioned associations with situational stimuli has ad-
vanced our understanding of nicotine addiction processes 
and has improved smoking cessation efforts. However, a 
likely contributor to the tenacity of nicotine dependence is an 
extension of the associative properties of nicotine. This exten-
sion includes nicotine’s interoceptive (subjective) stimulus, 
or CS, effects when reliably paired with another appetitive 
US (see Bevins & Palmatier, 2004). There has been a wealth 
of research in humans, monkeys, and rats showing that nic-
otine has interoceptive discriminative stimulus effects (e.g., 
Clements, Glautier, Stolerman, White, & Taylor, 1996; Mor-
rison & Stephenson, 1969; Takada, Hagen, Cook, Goldberg, 
& Katz, 1988; for a review see Stolerman, 1999). Recently the 
pharmacological stimulus effects of nicotine have also been 
shown to serve as a contextual CS for a sucrose US in rats 
(Besheer, Palmatier, Metschke, & Bevins, 2004; Bevins & Pal-
matier, 2004; Bevins, Penrod, & Reichel, 2007; Murray & Bev-
ins, 2007a, 2007b; Palmatier & Bevins, 2007; Reichel, Linku-
gel, & Bevins, 2007; Wilkinson, Murray, Li, Wiltgen, Penrod, 
Berg, & Bevins, 2006). In that research, a subcutaneous (sc) 
injection of nicotine or saline was given before placement 
in a conditioning chamber. On nicotine sessions, liquid su-
crose was delivered intermittently. On intermixed saline ses-
sions sucrose was not available. Using head entries into the 
sucrose receptacle before the first sucrose delivery as a mea-
sure of conditioning (i.e., goal tracking; Boakes, 1977; Far-
well & Ayres, 1979), nicotine readily served as a CS as evi-
denced by increased dipper entries on nicotine compared to 
saline sessions. Indeed, we now know some about the behav-
ioral processes (Besheer et al., 2004; Bevins et al., 2007; Mur-
ray & Bevins, 2007b; Palmatier & Bevins, 2007; Wilkinson et 
al., 2006) and some about the receptor systems (Murray & 
Bevins, 2007a; Reichel et al., 2007) involved in the CS effects 
of nicotine.
While investigating various characteristics of the Pavlov-
ian stimulus effects of nicotine, we have considered a vari-
ety of ways to extend that research to make the CS more sim-
ilar to smoking in a human. Human smokers generally have 
a loading dose of nicotine in the mornings with frequent re-
administrations that maintain desired blood levels through-
out the day (Benowitz, 1996; Russell, 1989). Each repeated nic-
otine intake temporarily lifts blood levels above baseline and 
is often accompanied by enhanced mood and increased cogni-
tive function (Parrott & Garnham, 1998; Parrott & Kaye, 1999; 
Warburton & Arnall, 1994). Indeed, these nicotine-induced 
enhancements can occur quite rapidly, after only a couple 
of puffs from a cigarette (Revell, 1988; Warburton & Arnall, 
1994), and may be reinforcing repeated self-administration in 
humans (Parrott, 2006). The animal models of human smok-
ing that are considered to have more face validity use iv nic-
otine rather than extravascular injections because of the faster 
increase in brain nicotine levels (see Benowitz, 1996; Matta et 
al., 2007). Intravenous administration, like inhalation, is not 
subject to the same process of drug absorption that occurs as 
a result of an extravascular injection (Benowitz, Porchet, & 
Jacob, 1990; Booze et al., 1999; Henningfield, Stapleton, Ben-
owitz, Greyson, & London, 1993). Indeed, iv infusions of 0.03 
mg/kg nicotine are common in rat models of nicotine self-ad-
ministration (e.g., Corrigall & Coen, 1989, 1991; Donny, Caggi-
ula, Knopf, & Brown, 1995; Donny, Caggiula, Mielke, Jacobs, 
Rose, & Sved, 1998). In those studies, rats have an operant re-
quirement (e.g., multiple presses on a predetermined lever) to 
complete before an infusion. Rats will increase pressing on the 
lever associated with nicotine infusions relative to an inactive 
lever, indicating that the nicotine infusions are serving as a re-
inforcer (LeSage, Keyler, Collins, & Pentel, 2003; LeSage, Key-
ler, Shoeman, Raphael, Collins, & Pentel, 2002; Palmatier et 
al., 2006; Rauhut, Dwoskin, & Bardo, 2005; Rauhut, Mullins, 
Dwoskin, & Bardo, 2002). Presumably, this low yet reinforc-
ing dose of nicotine is perceptible. If so, we hypothesized that 
a nicotine infusion would also function as an interoceptive CS 
for appetitive stimuli that occur in close temporal proximity.
The current study sought to test this hypothesis by assess-
ing whether brief iv infusions of nicotine could serve as CSs 
for sucrose. As part of this assessment, we eliminated alterna-
tive accounts of the CR by verifying that the nicotine infusions 
are controlling behavior. We also established that the nicotine 
CS is mediated by centrally localized nicotinic acetylcholine 
receptors (nAChRs). Finally, we determined that the CR is sus-
ceptible to extinction when sucrose is no longer delivered and 
to rapid reacquisition upon representation of the sucrose US. 
Indeed, the finding that iv nicotine functions as an appetitive 
CS in the present studies has opened up a wealth of future re-
search directions.
Experiment 1: Pavlovian Nicotine Discrimination
For Experiment 1 we used a discrimination procedure sim-
ilar to previous nicotine CS research with sc nicotine (e.g., 
Besheer et al., 2004). On a given training day, a rat received ei-
ther nicotine administration paired with sucrose deliveries or 
saline administration with no sucrose deliveries. The key dif-
ference of interest in the current experiment is that nicotine 
and saline were administered iv, multiple times within each 
session, and each nicotine infusion was followed by a single 
sucrose delivery. If nicotine functions as a CS in this situation, 
we expect it will come to control a centrally mediated CR. We 




Sixteen male Sprague–Dawley rats (338 ± 4 g before start 
of study) were obtained from Harlan (Indianapolis, Indiana). 
Rats were housed individually in clear 48.3 × 26.7 × 20.3 cm (l 
× w × h) polycarbonate tubs lined with wood shavings. Wa-
ter was continuously available in the home cage. Food (Har-
lan Teklad Rodent Diet) was restricted as described later. The 
colony was temperature and humidity controlled. All ses-
sions were conducted during the light portion of a 12 hr light:
dark cycle. Protocols were approved by the University of Ne-
braska-Lincoln Animal Care and Use Committee and followed 
the “Guide for the Care and Use of Laboratory Animals” (Na-
tional Research Council, 1996).
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Apparatus
Eight conditioning chambers (ENV-008CT; Med Associates, 
Inc., Georgia, VT) measuring 30.5 × 24.1 × 21.0 cm (l × w × h) 
were used in this experiment. Each chamber was enclosed in 
a light and sound attenuating polyvinyl chloride cubicle fit-
ted with a fan to provide airflow and mask noise. A houselight 
with two bulbs (28 V, 100 mA) was mounted on the back wall 
of the cubicle. It was centered side-to-side, 23.5 cm above the 
top of the conditioning chamber, and 5 cm below the ceiling 
of the cubicle. Chamber sidewalls were aluminum; the ceiling 
and front and back walls were clear polycarbonate. Chambers 
were equipped with a recessed receptacle (5.2 × 5.2 × 3.8 cm; l × 
w × d) on the right sidewall. A dipper arm raised a 0.1-ml cup 
of 26% sucrose solution (wt/vol) into the receptacle. An infra-
red emitter/detector unit, 1.2 cm into the receptacle and 3 cm 
from the floor, monitored head entries into the dipper. A sec-
ond infrared emitter/detector unit bisected the chamber 14.5 
cm from the sidewall containing the receptacle and was posi-
tioned 4 cm above the rod floor. This unit provided a measure 
of chamber activity. Each chamber had a computer-controlled 
variable-speed syringe pump (Med-Associates, PMH-100VS) 
that allowed solutions (nicotine or saline) to be delivered iv. 
Pumps were located outside the sound-attenuating cubicle. A 
spring leash hanging into the chamber from a swivel attached 
to a movable arm located outside the chamber was secured 
to the catheter. Tygon tubing (AAQ04103; VWR, West Ches-
ter, PA) extended from a 5-ml syringe mounted on the syringe 
pump through the leash to attach to the catheter. A personal 
computer with Med Associates interface and software (Med-
PC for Windows, version IV) controlled infusions and sucrose 
deliveries and recorded dipper entries and chamber activity.
Drugs
(–)-Nicotine hydrogen tartrate, hexamethonium bromide, 
and mecamylamine hydrochloride were purchased from 
Sigma (St. Louis, MO) or Tocris Cookson, Inc. (Ellisville, MO). 
Nicotine was mixed in 0.9% sterile saline and was adjusted 
to a pH of 7.0 ± 0.2 using a dilute NaOH solution. Nicotine 
doses are reported in the base form; remaining drug doses are 
reported in salt form. Rats were assigned nicotine solutions 
based on their daily weights within a 20 g range. Nicotine was 
infused over 1 second at 0.03 mg/kg/infusion at a volume of 
35.74 μl. Remaining drugs were mixed in 0.9% saline and in-
jected sc at 1 ml/kg, 15 minutes before testing.
Preliminary Training
Rats were handled for at least 3 minutes per day for 3 
days. Food was removed after handling on the last day. Dip-
per training began the following day. A 50-min session was 
conducted on each of 3 consecutive days with the session not 
starting until a rat’s first dipper entry. The probability of re-
ceiving sucrose decreased from 0.167 to 0.05 per 60 seconds 
over the three sessions (approximately 2.5 to 0.75 sucrose de-
liveries per minute). Rats received 20 g of food at the comple-
tion of the first two sessions; free access to food was returned 
following the third session.
Surgical Procedures
Surgical implantation of catheters occurred within 3 days 
of the last preliminary training session. Each rat was anesthe-
tized with an intraperitoneal (ip) injection (1 ml/kg) of ket-
amine hydrochloride (100 mg/ml) followed by an ip injection 
(0.6 ml/kg) of xylazine hydrochloride (20 mg/ml) purchased 
from Midwest Veterinary Supply (Des Moines, IA). One end 
of a silastic catheter (CamCaths IVSA28, Ely, Cambridgeshire, 
U.K.) was implanted into the external left jugular vein. The 
other end was positioned under the skin such that it exited 
just below the scapulae via a backmount through which the 
catheter was able to be accessed by a metal cannula. Buprenor-
phine hydrochloride (0.1 mg/kg) was injected sc immediately 
after surgery. For the evening and full day after surgery, bu-
prenorphine (0.5 mg/kg) was available in the drinking water 
to mange postsurgical pain. The catheter was flushed twice a 
day for the duration of the experiment with 0.2 ml of sterile 
saline mixed with heparin (30 Units/ml; Midwest Veterinary 
Supply) except for the first five postsurgical flushes in which 
0.1 ml of sterile heparinized saline was mixed with streptoki-
nase (ca. 8,000 Units/ml). Rats were allowed 5 days of recov-
ery in their home cage with free access to food before the start 
of the experiments. Catheter patency was assessed with a 0.05 
ml iv infusion of xylazine (20 mg/ml). This concentration pro-
duces clear motor ataxia within 5 seconds if the catheter is pat-
ent (cf. Bevins, 2005; Reichel, Linkugel, & Bevins, 2008; Weeks, 
1972). Only rats with patent catheters were included in analy-
ses of each phase in both experiments.
Training
Acquisition. Rats had 2-hr sessions once daily in which they 
received 10 infusions. On nicotine sessions, 4-s access to sucrose 
was given 30 seconds after each infusion. Sucrose was with-
held on saline sessions. To prevent rats from timing infusions, 
four different MedPC programs for each session type were 
created. The average time to the first infusion was 11 minutes 
with a range of 8 to 14 minutes; the average time between in-
fusions was also 11 minutes with a range of 8 to 14 minutes. To 
allow comparable measurement between nicotine (i.e., sucrose) 
and saline (i.e., no sucrose) sessions, the program types were 
matched for timing of infusions. Session types and programs 
were randomly interspersed with the restriction that no more 
than two nicotine or two saline sessions occurred in a row. The 
houselights were on for 1 minute before each session; the light 
offset signaled the start of the session. The end of the session 
was also signaled by 1 minute of chamber illumination.
Testing. After acquiring the discrimination, rats entered 
testing cycles. On the first two consecutive days of each 3-day 
cycle, rats received one nicotine and one saline session as de-
scribed earlier. If the rat met discrimination criteria, on Day 3 a 
test session occurred in place of a training session. To meet cri-
teria, a rat had to have higher conditioned responding (i.e., el-
evation scores; see later) on at least 7 of the 10 trials within the 
nicotine session compared to the corresponding trials within 
the saline session. If a rat did not meet the criteria, it contin-
ued to the next pair of nicotine and saline sessions. There were 
four tests. Rats received a sc injection of 5 mg/kg hexametho-
nium, 1 mg/kg mecamylamine, or 0.9% saline 15 minutes be-
fore chamber placement in a random order. A final test with 
0.5 mg/kg mecamylamine was added after rats completed the 
other three tests. Test sessions were the same as nicotine ses-
sions described previously (i.e., 10 nicotine infusions followed 
30 seconds later by sucrose).
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Extinction. Completion of the four test sessions was fol-
lowed by another nicotine and saline training session. Rats (n 
= 10) then received repeated nicotine sessions with no sucrose 
deliveries. Sucrose was reintroduced for each rat after that 
rat’s CR decreased by at least 50%.
Dependent Measures
The primary dependent measure was an elevation score: 
the number of dipper entries during the 30 seconds after the 
infusion minus the number of dipper entries in the 30-s inter-
val before the infusion. The elevation score is a common mea-
sure in related Pavlovian conditioning research (e.g., Morris & 
Bouton, 2006; Murray, Li, Palmatier, & Bevins, 2007; Palmatier 
& Bevins, 2007; Simon & Setlow, 2006). A positive value indi-
cates more dipper entries during the CS; 0 indicates no change 
from the interval before the CS. We also measured total dipper 
entries to examine changes across sessions, and as an index of 
activity, the number of infrared beam breaks in the chamber 
was also measured.
Data Analyses
Acquisition of the discrimination was examined using two-
way repeated measures factorial analyses of variance (ANO-
VAs) with Drug (nicotine vs. saline) as one factor and either 
Trial or Session (mean of the 10 trials) as the other factor. Re-
sponding on test sessions was examined using a one-way re-
peated measures ANOVA comparing Test Drug. Respond-
ing across trials within the test sessions was examined using 
a two-way repeated measures ANOVA with Test Drug as one 
factor and Trial as the other factor. Significant interactions 
were followed by pairwise comparisons using Fisher’s Least 
Significant Difference (LSD) tests. Statistical significance was 
declared using a p-value less than .05 for all tests.
Results
Acquisition
Figure 1 shows that rats readily acquired the nicotine-saline 
discrimination. Using the measure of mean elevation scores 
shown in Figure 1A, there were significant main effects of 
Drug, F(1, 15) = 113.85, p < .001, and Session, F(5, 75) = 25.49, 
p < .001, and a significant Drug × Session interaction, F(5, 75) 
= 17.32, p < .001, mean square error (MSE) = 2.70. Elevation 
scores were higher on nicotine than saline for all sessions, LSD-
mimimum mean difference (mmd) = 1.16. This pattern was also reflected 
across trials as shown in Figure 1B. There was a main effect 
Figure 1. Panel A shows the mean elevation scores (±1 SEM) of acquisition for nicotine and saline sessions of Experiment 1. Panel B shows acquisition 
of the nicotine and saline discrimination (+1 SEM) across each trial. Panel C shows mean total dipper entries (±1 SEM) across each session for 
acquisition. Panel D shows mean chamber activity counts (±1 SEM) for each session. The vertical dashed line in Panels A, C, and D denote the start 
of testing. The dashed lines in Panel B separate the trials of each session. The asterisk denotes significant difference between nicotine and saline.
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of Drug, F(1, 15) = 113.85, p < .001, a main effect of Trial, F(59, 
885) = 8.34, p < .001, and a Drug × Trial interaction, F(59, 885) = 
6.19, p < .001, MSE = 9.25. Elevation scores were higher on nic-
otine than saline for Trials 7, 13 through 20, and 22 through 60, 
LSDmmd = 2.11. Importantly, the first trial within sessions was 
higher on nicotine than saline for Sessions 4 through 6 (i.e., 
Trials 31, 41, and 51) indicating that the interoceptive stimulus 
effects of nicotine and not the initial sucrose delivery served as 
the cue for session type. As goal tracking came under stimulus 
control, total dipper entries (Figure 1C) in the 2-hr nicotine ses-
sions decreased. There were significant main effects of Drug, 
F(1, 15) = 64.68, p < .001, and Session, F(5, 75) = 15.59, p < .001, 
and a significant Drug × Session interaction, F(5, 75) = 4.93, p = 
.001, MSE = 36039.32. Total dipper entries were higher on nic-
otine than saline for Sessions 1 through 5, LSDmmd = 134.24; 
there was no difference on Session 6. For total chamber activ-
ity (Figure 1D), rats showed a general decrease in activity with 
repeated sessions. There was a main effect of Drug, F(1, 15) = 
28.06, p < .001, indicating higher activity on nicotine than on 
saline. There was also a main effect of Session, F(5, 75) = 5.33, 
p < .001, MSE = 30192.77, denoting more activity in general on 
Session 1 than on Sessions 4, 5, and 6, LSDmmd = 86.88, but no 
Drug × Session interaction, F(5, 75) = 1.20, p = .319. 
Testing
Pretreatment with mecamylamine, but not hexametho-
nium, blocked conditioned responding evoked by the iv nic-
otine CS, F(3, 45) = 17.15, p < .001, MSE = 6.06. Mean elevation 
scores (Figure 2A) were lower with 1 and 0.5 mg/kg mecamyl-
amine pretreatment than saline pretreatment, LSDmmd = 1.76. 
Further examination showed this effect was consistent across 
trials (Figure 2B). There were main effects of Test Drug, F(3, 
45) = 17.15, p < .001, and Trial, F(9, 135) = 7.82, p < .001, and 
a significant Test Drug × Trial interaction, F(27, 405) = 1.81, p 
= .009, MSE = 12.89. For Trials 2 through 9, elevation scores 
were lower after pretreatment with 1 mg/kg mecamylamine 
than pretreatment with saline, and for Trials 2 through 5 and 
7 through 9, elevation scores were lower after pretreatment 
with 0.5 mg/kg mecamylamine than pretreatment with saline. 
There were higher elevation scores on Trials 3 and 6 for 5 mg/
kg hexamethonium pretreatment than saline pretreatment, LS-
Dmmd = 2.49. There was no significant effect of Test Drug (Fig-
ure 2C) on chamber activity, F(3, 45) = 2.66, p = .06. 
Extinction
Removing sucrose deliveries from the nicotine sessions re-
duced the nicotine-evoked CR (see Figure 3). Elevation scores 
for the rats’ first extinction session were lower than their last 
nicotine session before extinction, t(9) = 2.77, p = .022. Re-
sponding further decreased between the first and last extinc-
tion sessions (range of 3–7 sessions), t(9) = 6.69, p < .001. Re-
sponding recovered when sucrose was returned compared to 
responding on the last extinction session, t(9) = 4.04, p = .003. 
Discussion
The interoceptive effects of a low dose of iv nicotine func-
tioned as a CS for an appetitive outcome as shown by the dif-
ferential responding on nicotine compared to saline sessions. 
This discrimination cannot be explained by the first sucrose 
delivery of the nicotine sessions being an indicator that subse-
quent infusions will be followed by sucrose. That is, differen-
tial responding was evoked by the first infusion of each session 
later in training, indicating that iv nicotine was responsible for 
the CR.
Figure 2. Panel A shows mean elevation scores (+1 SEM) for the test 
sessions of Experiment 1. The asterisk denotes significant difference 
from saline pretreatment. Panel B shows mean elevation scores (±1 
SEM) for each trial of the test sessions. Significant differences from 
saline pretreatment are described in the text. Panel C shows mean (+1 
SEM) total activity counts during test sessions.
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Consistent with the previous studies that used an extravas-
cular injection of nicotine as the CS (e.g., Besheer et al., 2004), 
the CS effects of nicotine infusions were centrally mediated. 
Hexamethonium, an nAChR antagonist that only weakly pen-
etrates the blood–brain barrier (Asghar & Roth, 1971), did not 
alter nicotine-evoked conditioned responding. Although only 
a single dose of hexamethonium was examined in the present 
study, this dose is often used for testing the central actions of 
nicotine (e.g., Besheer et al., 2004; Brazell et al., 1991; Loughlin 
et al., 2006; Stolerman et al., 1984). Mecamylamine, a nAChR 
antagonist that blocks both central and peripheral receptors 
(Papke, Sanberg, & Shytle, 2001), blocked the CR relative to sa-
line pretreatment throughout the entire session.
Blockade of conditioned responding by mecamylamine pre-
treatment also suggests that peripheral effects of the infusions 
are not sufficiently perceptible to control conditioned respond-
ing. If the infusion alone (i.e., not the nicotine) was perceptible, 
then responding would likely have increased across trials dur-
ing test sessions because the sucrose presentations would have 
been signaled. It should be noted that saline pretreatment re-
duced the first elevation score of the test session compared to 
training levels. We attribute this effect to external inhibition of 
the injection procedure. Because an injection had never previ-
ously occurred before a training session, the CR was slightly 
inhibited when the change in procedure occurred (see Pavlov, 
1927). Notably, the injection procedure was the same for all 
test drugs including saline, making the findings across the test 
sessions comparable.
Finally, there was a nonsignificant trend for a decrease in 
chamber activity with mecamylamine dose that coincided with 
a more robust and significant decrease in elevation scores (i.e., 
conditioned responding). This data pattern suggests a poten-
tial relation between the conditioned response and locomotor 
activity during the mecamylamine tests. To assess this possi-
bility, we conducted a multiple regression analysis using Drug 
Dose (saline, 0.5, and 1 mg/kg mecamylamine), Activity, and 
Rat Weight as the predictors for the Elevation Score. We in-
cluded Weight as a predictor for two reasons. First, size of the 
rats might affect mobility in the in the chamber and hence al-
ter dipper entries. Second, the size of the rat might affect ab-
sorption and distribution of mecamylamine or nicotine. Ele-
vation scores were significantly predicted by the three-factor 
model, r2 = .409, F(3, 44) = 10.14, p < .001. There was a signif-
icant contribution of Drug Dose, β = .54, p < .001, but Activ-
ity and Weight did not contribute to the model, βs ≤ .205, p ≥ 
.102. This model indicates a preferential impact of mecamyla-
mine, not activity or body weight, on nicotine-evoked condi-
tioned responding.
Finally, when repeated nicotine sessions were given with-
out sucrose (i.e., extinction) conditioned responding decreased. 
This result extends research using sc injections of nicotine as a 
contextual CS (Besheer et al., 2004; Murray & Bevins, 2007b; 
Wilkinson et al., 2006) showing that the CR evoked by nicotine 
reflects a conditioned association between the iv nicotine infu-
sion and the sucrose delivery. Indeed, an alternative account 
of the increased dipper entries with nicotine is that psychomo-
tor stimulant effects of the nicotine somehow increased this 
behavior (e.g., Bevins & Palmatier, 2003; Shoaib & Stolerman, 
1992). The reduction of the CR during extinction diminishes 
the feasibility of this account because nicotine is still being 
given in those sessions. In addition, reintroduction of sucrose 
after extinction resulted in reacquisition of the CR to nicotine 
in a single session. Taken together, these results support the 
conclusion that the interoceptive stimulus effects of iv nicotine 
were serving as an appetitive CS.
Experiment 2: Importance of Temporal Contiguity
Experiment 2 was designed to extend the conditions under 
which the CR is observed and to provide a control to assess 
nonassociative accounts of increased dipper entries in Exper-
iment 1. As such, we trained one group with CS·US pairings 
as described previously and another group with explicitly 
Figure 3. This figure shows mean elevation scores (+1 SEM) for the first and last extinction sessions of Experiment 1. The figure also shows the 
last nicotine training session before extinction and the sucrose session following extinction. The asterisk denotes significant difference between 
sessions.
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unpaired CS and US presentations (e.g., Servatius, Brennan, 
Beck, Beldowicz, & Coyle-DiNorcia, 2001; Tiffany, Drobes, & 
Cepeda-Benito, 1992). If dipper entries increased after nicotine 
infusions in the Unpaired group, it would suggest that nonas-
sociative factors (see later) are responsible for the effects seen 
in Experiment 1.
Method
Subjects, Apparatus, and Drugs
Fifteen male Sprague–Dawley rats (333 ± 2 g before start of 
study) were housed and maintained as described earlier. The 
apparatus was unchanged, and nicotine was prepared and ad-
ministered as described in Experiment 1.
Preliminary Training and Surgical Procedures
Rats were given the same preliminary training, surgical im-
plantation of catheters, and recovery as described in Experi-
ment 1.
Training
Acquisition. Rats were assigned to either the Paired group 
or the Unpaired group irrespective of preliminary training 
performance. Rats in the Paired group (n = 7) received 10 nic-
otine infusions followed 30 seconds later with 4-s access to su-
crose. The average time to the first infusion was 11 minutes 
with a range of 8 to 14 minutes; the average time between in-
fusions was also 11 minutes with a range of 8 to 14 minutes 
(cf. nicotine sessions of Experiment 1). Rats assigned to the 
Unpaired group (n = 8) received nicotine infusions explicitly 
unpaired with sucrose deliveries. The timing of infusions was 
identical to the Paired group. Sucrose deliveries were tempo-
rally spaced at least 4 minutes from nicotine infusions. Acqui-
sition training continued for seven sessions.
Extinction. After acquisition, sucrose presentations were 
withheld for 11 consecutive sessions (i.e., extinction). Nicotine 
infusions were continued as described in acquisition.
Dependent Measures and Data Analyses
Dipper entries and activity were measured as described for 
Experiment 1. Acquisition and extinction were examined us-
ing two-way mixed Groups ANOVAs with Group (Paired vs. 
Unpaired) as the between-subjects factor and Trial or Session 
(mean of the 10 trials) as the within-subjects factor. Significant 
interactions were followed by pairwise comparisons using 
Fisher’s LSD tests. Statistical significance was declared using a 
p-value less than .05 for all tests.
Results
Acquisition
Figure 4A shows that the Paired group acquired a nicotine-
specific CR; the Unpaired group did not selectively respond in 
the 30-s after the nicotine infusions. There were main effects of 
Group, F(1, 13) = 114.61, p < .001, and Session, F(6, 78) = 5.17, 
p < .001, and a significant Group × Session interaction, F(6, 78) 
= 2.68, p = .020, MSE = 5.45. Elevation scores were higher on 
all sessions for the Paired group compared to the Unpaired 
group, LSDmmd = 2.41. The same pattern was reflected across 
trials (Figure 4B). There was a main effect of Group, F(1, 13) = 
109.19, p < .001, and of Trial, F(69, 897) = 50.24, p < .001, but 
no Group × Trial interaction, F(69, 897) = 1.15, p = .193. Ele-
vation scores by trial were higher for the Paired group than 
the Unpaired group, Ms = 5.87 ± 0.469 and −0.83 ± 0.438, re-
spectively. Similar to Experiment 1, total dipper entries (Fig-
ure 4C) decreased as goal tracking came under stimulus con-
trol. The Paired group also had more total dipper entries than 
the Unpaired group. There were main effects of Group, F(1, 
13) = 6.54, p = .024, and Session, F(6, 78) = 13.85, p < .001, but 
no Group × Session interaction, F(6, 78) = 1.13, p = .351. There 
was no difference between groups on chamber activity (Fig-
ure 4D), Fs ≤ 2.18, ps ≥ .054. 
Extinction
Figure 5A shows that removal of sucrose deliveries reduced 
the CR in the Paired group to the level of the Unpaired group. 
There were main effects of Group, F(1, 12) = 48.69, p < .001, 
and Session, F(10, 120) = 8.84, p < .001, and a significant Group 
× Session interaction, F(10, 120) = 8.58, p < .001, MSE = 0.79. 
The Paired group had higher elevation scores than the Un-
paired group on extinction Sessions 1 through 6 and 8 through 
10, LSDmmd = 0.94. This pattern was also shown across trials 
(Figure 5B). There were main effects of Group, F(1, 12) = 48.69, 
p < .01, and Trial, F(109, 1308) = 2.00, p < .05, and a signifi-
cant Group × Trial interaction, F(109, 1308) = 1.93, p < .05, MSE 
= 7.86. The Paired group had higher elevation scores than the 
Unpaired group for extinction Trials 1–14, 18, 24–27, 29, 32–
33, 35–36, 38–39, 42, 51, 58, 79, 86, 93, and 102, LSDmmd = 2.94. 
There was no difference between groups for total dipper en-
tries (Figure 5C), Fs ≤ 1.36, ps ≥ .207, or chamber activity (Fig-
ure 5D), Fs ≤ 1.49, ps ≥ .152. 
Discussion
Only rats in the Paired group showed increased dipper en-
tries immediately following nicotine infusions, indicating the 
importance of contiguity between the CS and US in acquisi-
tion of conditioned responding. Although the Unpaired group 
received equal nicotine presentations and sucrose deliveries, 
they were not temporally contiguous, and rats did not develop 
the CR. These findings from the Unpaired group eliminate 
nonassociative accounts of the increased goal tracking seen in 
Experiment 1 and in the Paired group of this experiment. One 
nonassociative property of nicotine that has received a lot of 
recent attention is its reward-enhancing effects (e.g., Chaudhri 
et al., 2006, 2007; Donny et al., 2003; Olausson, Jentsch, & Tay-
lor, 2003; Palmatier et al., 2006). In the current task, repeated 
sucrose presentations may be imbuing the goal receptacle with 
conditioned appetitive properties. If nicotine is responsible for 
enhancing the salience or appetitive quality of the goal recep-
tacle, then each infusion would be followed by an increase in 
dipper entries. Because the groups received equal amounts 
of sucrose, goal receptacle quality would be enhanced to an 
equivalent degree, and elevation scores would have been simi-
lar in the two groups. This explanation, however, requires that 
rats in the Unpaired group access the sucrose so the goal re-
ceptacle acquires those similar appetitive properties. Elimina-
tion of such an account assumes that associative properties of 
nicotine are evoking the increase in dipper entries. We verified 
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that rats were engaged in at least one dipper entry during each 
4-s sucrose presentation. The Paired group retrieved 91.2% of 
their deliveries, and the Unpaired group retrieved 90.5% of 
their sucrose deliveries, confirming that conditioned appeti-
tive properties of the goal receptacle were not driving dipper 
entries after nicotine infusions.
Finally, similar to Experiment 1, repeated nicotine presen-
tations without sucrose resulted in a gradual decrease in con-
ditioned responding across sessions in the Paired group. This 
decrease continued until it reached the response level of the 
Unpaired group. There was no change in dipper entries for the 
Unpaired group. Combined, these data support that the condi-
tioned responding reflects a CS·US association.
General Discussion
The results of the two experiments in this report are con-
sistent with the notion that the central nervous system (CNS) 
effects of a low dose of iv nicotine function as an appetitive 
CS. Nicotine is well-known to have profound effects in the 
periphery such as muscle control (e.g., Lembeck, 1999), va-
sodilation (e.g., Eguchi, Miyashita, Kitamura, & Kawasaki, 
2007), and anti-inflammatory enhancement (e.g., Ulloa, 2005). 
However, blockade of peripheral nAChRs with hexametho-
nium did not alter the CR, whereas blockade of central and 
peripheral nAChRs blocked the CR, leaving the CNS to selec-
tively mediate the nicotine CS. Notably, the present research 
also demonstrates a host of phenomena widely studied in 
more traditional Pavlovian conditioning tasks with discrete 
exteroceptive stimuli. This list includes an increase in condi-
tioned responding with an increased number of trials (e.g., 
Kalish, 1954) and the importance of temporal contiguity (e.g., 
Murphy & Baker, 2004) during acquisition. In addition, there 
is a loss of conditioned responding with removal of the US 
(e.g., Ayres & DeCosta, 1971) followed by fast reacquisition 
of the CR upon US representation (e.g., Tomie, Hayden, & 
Biehl, 1980).
Indeed, even the striking pattern of within-session condi-
tioned responding during acquisition fits within a framework 
of learning theory. Early session infusions controlled lower 
levels of responding than infusions later in the session, fol-
lowed by a downturn toward the end of the session. This in-
verted-U pattern of conditioned responding within sessions is 
similar to those studied in both Pavlovian and operant condi-
tioning tasks (e.g., McSweeney, 1992; Servatious et al., 2001). 
A dual process theory of responding has been used to explain 
this pattern (see Groves & Thompson, 1970; McSweeney & 
Hinson, 1992). That account suggests that the first part of the 
pattern, the lower responding in the early portion of the ac-
quisition sessions followed by increases across trials, may be 
the result of a response sensitization effect of the CS·US asso-
ciation. That is, repeated presentations of the stimuli enhance 
Figure 4. Panel A shows mean elevation scores (±1 SEM) of each session of acquisition for Paired and Unpaired groups of Experiment 2. Panel B 
shows elevation scores (+1 SEM) across trials. Panel C shows mean total dipper entries (±1 SEM) across each session. Panel D shows mean chamber 
activity counts (±1 SEM) for each session. The vertical dashed lines in Panel B separate the trials of each session. The asterisk denotes significant 
difference between Paired and Unpaired groups.
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responsiveness. For example, in a study of the mouthing re-
sponse to food in rat pups, initial presentations resulted in in-
creased rates of responding (Swithers-Mulvey & Hall, 1992; 
see also McSweeney & Swindell, 1999). Similarly, in an oper-
ant task in which rats were trained to leverpress for food pel-
lets there was an initial increase in response rates in the early 
portion of the sessions (McSweeney, 1992; see also McSwee-
ney, Hinson, & Cannon, 1996).
The response rates in both types of studies reached a peak 
level, and then declined. Similarly, in the current research the 
decrease in responding on the later trials may be an effect of 
CS·US habituation because of decreased strength of the moti-
vated goal-tracking behavior after repeated contact with the 
sucrose goal (McSweeney & Swindell, 1999). Alternatively, 
the later trial responding can be explained pharmacologically. 
As each successive infusion accumulates into the background 
brain nicotine level during the session, the perceptible change 
brought about by each infusion may be decreasing, resulting 
in decreased responding. This account, however, cannot ex-
plain the response pattern of early trials. After 22 hours since 
finishing the previous session, brain nicotine levels in the rats 
would be nearly nothing. Therefore, the first several infusions 
should be highly perceptible and hence evoke a strong CR. In-
terestingly, the different subtypes of nAChRs responsible for 
the behavioral effects of nicotine differentially respond to nic-
otine administration (e.g., McGehee, Heath, Gelber, Devay, & 
Role, 1995; Pidoplichko, DeBiasi, Williams, & Dani, 1997) and 
may help explain the response pattern in early trials. After ac-
tivation, some receptors are desensitized to further effects of 
nicotine much more readily than others (e.g., Fenster, Rains, 
Noerager, Quick, & Lester, 1997; Wooltorton, Pidoplichko, 
Broide, & Dani, 2003). The effects of those receptors that ex-
perience prolonged desensitization following activation may 
predominate during the first couple infusions; however, those 
effects would not be available for conditioning in later trials. 
Perhaps the CR in the current research is selectively mediated 
by receptors that do not remain in a desensitized state during 
chronic nicotine exposure. Of course, more research will be re-
quired to determine the actual processes responsible for the 
pattern of conditioned responding.
Upon examination of the extinction across trials, a sec-
ond series of intriguing within-session patterns is visible in 
the Paired group. There is an initial burst in conditioned re-
sponding early in sessions that drops off in later parts of the 
sessions. These early session increases might reflect spontane-
ous recovery of the CR (Bouton, 1993; Pavlov, 1927; Rescorla, 
1997, 2004). The subsequent responding within each session 
then gradually tapers off across trials when the US does not 
appear. Between sessions, the degree of this apparent sponta-
neous recovery gradually diminishes with continued CS alone 
exposure. Notably, spontaneous recovery is regarded as one 
of the ‘threats to extinction’ of drug use (see Conklin & Tif-
Figure 5. Panel A shows mean elevation scores (±1 SEM) of each session of extinction for Paired and Unpaired groups of Experiment 2. Panel B 
shows elevation scores (+1 SEM) across trials. Panel C shows mean total dipper entries (±1 SEM) across each session. Panel D shows mean chamber 
activity counts (±1 SEM) for each session. The vertical dashed lines in Panel B separate the trials of each session. The asterisk denotes significant 
difference between Paired and Unpaired groups.
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fany, 2002). Therefore, spontaneous recovery of a CR evoked 
by a nicotine CS may also contribute to tobacco addiction.
Perhaps the most exciting aspects of the present research 
are the empirical and theoretical advances for future studies. 
For example, having a single nicotine infusion paired with a 
single sucrose delivery permits trial-by-trial measures of the 
nicotine CS-US association. How responding changes across 
a session and manipulations of the intertrial and interstimu-
lus intervals could offer a clearer picture of the associability 
of the infusions. Within-session manipulations would also be 
possible, allowing examinations of higher-order associations 
such as the addition of positive or negative features that indi-
cate when the nicotine·sucrose association is active. Because iv 
nicotine is used in animal models of self-administration, and 
because the iv route of administration is generally considered 
to have more face validity than extravascular routes of admin-
istration (see Benowitz, 1990; Matta et al., 2007), we can also 
better examine the possibility that a stimulus such as nicotine 
may be able to serve multiple roles at the same time (i.e., as a 
reinforcer and as a CS). The ability of nicotine to “multitask” 
has been shown by Caggiula and colleagues who have demon-
strated that nicotine can be a primary reinforcer while simulta-
neously enhancing the reinforcing effects of other stimuli (e.g., 
Chaudhri et al., 2006, 2007; Palmatier et al., 2006). As such, it is 
of interest to determine whether the CS effects of nicotine can 
modify the rate of iv nicotine self-administration when the CS 
properties are manipulated. If so, these multifaceted character-
istics of nicotine can be incorporated into models of tobacco 
dependence and relapse. It may be the case that the limited ef-
ficacy of behavioral therapy as a smoking cessation technique 
could be because of the need to consider this CS property of 
nicotine along with other aspects of the individual’s learning 
history. These therapies rely on repeated, nonreinforced ex-
posure of drug-related stimuli (see Conklin, 2006; Conklin & 
Tiffany, 2002). If the stimulus properties of nicotine are capa-
ble of forming compound CSs with the environmental stim-
uli that are extinguished during cue-exposure therapy, it may 
be a step in explaining the partial effectiveness of these ther-
apies. Using iv nicotine as a CS would relatively easily allow 
for examination of cue competition between nicotine and other 
stimuli. Overall, this research could significantly enhance our 
understanding of how the nicotine in tobacco may modulate 
behavior, and subsequently enhance the success of cessation 
treatments.
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